Ozempic maker Novo Nordisk to spend $4.1 billion to boost production
Novo Nordisk on Monday said it will invest $4.1 billion in a new Clayton, N.C., manufacturing facility as it works to meet surging demand for its popular injectable drugs Wegovy and Ozempic.
